RACHEL MCKINNEY: Open Payments
NPI 1396399440 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 11 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Lundbeck LLC | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
Products named: REXULTI, CAPLYTA, INGREZZA, REPATHA, Cologuard Collection Kit, SHINGRIX, BREZTRI, MOUNJARO.
Industry payments across WY — which companies pay providers there.
